The FDA's Vaccines and Related Biological Products Advisory Committee unanimously recommended the approval of a cancer vaccine on May 18. The drug, Gardasil, which is manufactured by Merck, will fight against four strands of the human papilloma virus (HPV) that has been linked to cervical cancer.